Author:
Himuro Hidetomo,Sasada Tetsuro
Reference87 articles.
1. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy;Coulie;Nat Rev Cancer,2014
2. Tumor neoantigens: building a framework for personalized cancer immunotherapy;Gubin;J Clin Invest,2015
3. Towards personalized, tumour-specific, therapeutic vaccines for cancer;Hu;Nat Rev Immunol,2018
4. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine;Hu;Cancer Res,1996
5. Cancer immunotherapy: moving beyond current vaccines;Rosenberg;Nat Med,2004